Your search for ganciclovir returned 17 results

Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects.

For patients with glioblastoma, treatment with valganciclovir is associated with improved survival.

Letermovir is currently marketed under the brand name Prevymis for prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic HSCT.

The new approvals include Besremi, Fyarro, Livtencity, Voxzogo, and Vuity.

Livtencity is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates.

Maribavir is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates.

The NDA submission is supported by data from the multicenter, randomized, open-label, active-controlled phase 3 TAK-620-303 (SOLSTICE) trial.

Foscarnet sodium injection is indicated to treat cytomegalovirus retinitis in patients with AIDS and acyclovir-resistant mucocutaneous HSV in immunocompromised patients.

Options include acyclovir, valacyclovir, topical ganciclovir; need for development of new compounds

Criteria for diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well as treatment options are addressed in two systematic evidence reviews published in the Annals of Internal Medicine.